draft
 

Application to Present

Biotechnology companies interested in partnering their technologies or products, initiating strategic alliances, or tapping into the European financing network are welcome to apply to present at BIO-Europe Spring 2008.
A panel of industry experts will select the presenting companies. The panel will make each decision based on the company profile that was submitted (deadline: December 14, 2007) and on the interests of the pharmaceutical companies, consistency with BIO-Europe Spring’s focus and the licensability of products or technology.

   
Registration Fee
 
  Euro US$
850 euro + 7% VAT
US$ 1,050 + 7% VAT
Regular Registration Fee
(after February 1, 2008)
1,690 euro + 7% VAT
US$ 1,890 + 7% VAT
 
..

North American Registrants will be invoiced in USD. All others please remit in Euro.

..
VAT will be added as applicable.
..
Companies that applied to present must submit their profile by December 14, 2007.
..
Additional attendees from the same company will be invoiced for the registration fee.
..
Companies with 3 full-paying delegates will receive 1 complimentary ticket for the 4th attendee from their company.
   
   
Your registration fee includes
 
  • access to all workshops, presentations, panel discussions and the exhibition hall
  • participation in the partnering process
  • conference book
  • all conference dinner events
  • coffee breaks and lunches
   
   
VAT Reclaim
 

For information on VAT refunds click here.

   
   
Profile/Conference CD
  Company profiles received after March 21, 2008 will not be included on the BIO-Europe Spring 2008 conference CD. However, your company profile will be published in the password-protected Partnering section of the BIO-Europe Spring Web site.

For Sponsors and Exhibiting companies only: the deadline for submitting your profile for the printed conference book is March 17, 2008. Changes made after March 17 will not be included in the conference book however, your company profile will be published in the password-protected Partnering section of the BIO-Europe Spring Web site.
   
   
Each company will be allowed 15 minutes for their presentation, which should focus on the following areas:
 
  • Brief corporate background
  • Licensing opportunities in
    • Key technology
    • Product / clinical development
  • Type of alliances sought
  • Existing alliances
   
  If you need guidance for your presentation you may download our presenter guidelines (PDF).
   
   
Payment
  Presenting companies will receive an invoice shortly after they have been selected.
   
   
Cancellation Policy
  Cancellations must be sent in writing by February 22, 2008, to fax number 49 (89) 2388 756-55 to receive a refund (minus 250 Euro processing fee). Refunds will be processed after BIO-Europe Spring 2008.
After February 22, 2008, the full registration fee is applicable. However, a paid up registration is transferable to a replacement from your company.
NB: No-shows will be billed for the full registration fee.
   
   
Deadlines
  Deadline for applying to present: December 14, 2007
We will notify you about the status/outcome of your application by mid January, 2008.  The notification will also contain a link to your online invoice and payment instructions.
   
   
Biotech Application Form
  The deadline for submitting an application to present has already passed.

Selected companies will be notified by in January.

   
  If you are interested in presenting and want to be placed on our waiting list please contact:

Martina Rannertshauser
EBD Group
Phone +1 (760) 930 0500
Fax +1 (760) 930 0520
mrannertshauser@ebdgroup.com
   

 
 
COMPANY PRESENTATION INFO
The deadline for submitting an application to present has already passed.

Selected companies will be notified end of January.

 
If you are interested in presenting and want to be placed on our waiting list please contact:
 

Martina Rannertshauser
EBD Group
Phone +1 (760) 930 0500
Fax +1 (760) 930 0520
mrannertshauser@ebdgroup.com

..............................................................................
 
© 2007-2008 EBD Group AG